Su Wang, MD, MPH, FACP is the Medical Director of Viral Hepatitis Programs & the Center for Asian Health at the Cooperman Barnabas Medical Center, RWJBarnabas Health. She serves as Global Health advisor for the Hepatitis B Foundation and was previously president of the World Hepatitis Alliance. She has served as primary investigator for a number of viral hepatitis screening, vaccination & linkage-to-care studies sponsored by the CDC and other funders. Dr. Wang has led primary care-based hepatitis B and C programs, community & hepatitis based screening initiatives, community based research and advocacy efforts. Dr. Wang is currently on WHO's Global Validation Advisory Committee which supports country efforts of prevention of mother to child transmission (PMTCT) for triple elimination of HIV, syphilis and HBV. She has served on a number of committess for WHO guidelines, including the "Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection" released in 2024. She received her Medical Degree from the University of Miami and her Masters of Public Health from Johns Hopkins School of Public Health. Dr. Wang completed a combined Internal Medicine and Pediatric residency at Georgetown University Hospital and then served as an Epidemic Intelligence Service officer for the Centers for Disease Control and Prevention (CDC) at the US Food and Drug Administration (FDA). She was previously the Director of Hepatitis Programs at the Charles B. Wang Community Health Center in New York City.